{"schema_version":"1.0","type":"article","title":"SpaceX Goes to Orbit. Is the Money in the Crystals?","url":"https://drugnews.com.tw/articles/2026-07-24-spacex-microgravity-drug-crystals-en.html","markdown_url":"https://drugnews.com.tw/articles/2026-07-24-spacex-microgravity-drug-crystals-en.md","lang":"en","date":"2026-07-24","publish_at":"2026-07-24T16:20:00+08:00","updated_at":"2026-07-24","category":"商業分析系列","topic":"商業分析系列","tags":["SpaceX","microgravity","space pharmaceuticals","drug crystallization","Keytruda","Redwire","SpaceMD","Varda","formulation development","Taiwan biotech"],"summary":"SpaceX is making low-Earth-orbit round trips more routine, but rockets do not discover drugs. From Keytruda crystallization and SpaceMD to Varda, UK regulation, and a Taiwan mission, this analysis asks whether microgravity-enabled manufacturing can pass the tests of repetition, scale-up, and regulation.","key_points":[],"facts":[],"sections":["01 | SpaceX Is Turning Orbit into a Laboratory That Can Be Revisited","02 | Keytruda's Trip to Space Became a Lesson in Formulation Physics","03 | One Orbit, Three Emerging Business Models","04 | The Added Value from Orbit Must Pass Four Commercial Gates","05 | Taiwan Has Already Sent a Protein-Crystallization Experiment into Orbit","06 | Around 2030, Orbital Laboratory Capacity Will Also Be Repriced","Conclusion | The Next Formulation Answer May Take a Detour through Space","Primary Sources","Disclaimer"],"references":[{"title":"[Redwire/SpaceMD]","source":"","date":"","url":"https://ir.rdw.com/news-events/press-releases/detail/235/former-merck-and-nasa-leaders-bring-strategic-expertise-to"},{"title":"[NASA/SpaceX CRS-34]","source":"","date":"","url":"https://www.nasa.gov/missions/station/iss-research/nasas-spacex-crs-34-dragon-returns-packed-with-space-station-science/"},{"title":"[NASA June 17, 2026 Dragon splashdown log]","source":"","date":"","url":"https://www.nasa.gov/blogs/spacestation/2026/06/17/spacex-dragon-splashes-down-in-pacific-completes-cargo-mission/"},{"title":"[npj Microgravity: pembrolizumab crystallization in microgravity]","source":"","date":"","url":"https://www.nature.com/articles/s41526-019-0090-3"},{"title":"[NASA: Space Station Research Informs New FDA-Approved Cancer Therapy]","source":"","date":"","url":"https://www.nasa.gov/missions/station/iss-research/space-station-research-informs-new-fda-approved-cancer-therapy/"},{"title":"[FDA: Keytruda Qlex]","source":"","date":"","url":"https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-and-berahyaluronidase-alfa-pmph-subcutaneous-injection"},{"title":"[Varda Space Industries mission platform]","source":"","date":"","url":"https://www.varda.com/platform"},{"title":"[npj Microgravity: Varda ritonavir Form III]","source":"","date":"","url":"https://www.nature.com/articles/s41526-026-00594-0"},{"title":"[UK government: regulatory pathway for space-manufactured drugs]","source":"","date":"","url":"https://www.gov.uk/government/news/uk-sets-out-world-leading-pathway-for-space-manufactured-drugs"},{"title":"[Space BD: NSRRC protein crystallization in space]","source":"","date":"","url":"https://www.space-bd.com/dam/include-content/PUBLIC/en/news_archive/storage/news20220303-001/pdf/20220520en-4.pdf"},{"title":"[HelioX Cosmos]","source":"","date":"","url":"https://www.helioxcosmos.com/about/ABOUT-US/"},{"title":"[Shanghai Institute of Materia Medica]","source":"","date":"","url":"https://simm.cas.cn/web/xwzx/kydt/202508/t20250801_7900455.html"},{"title":"[Chinese Academy of Sciences/SIMM English release]","source":"","date":"","url":"https://english.simm.cas.cn/News/Headline/202508/t20250829_1051693.html"},{"title":"[NASA: Commercial Space Stations]","source":"","date":"","url":"https://www.nasa.gov/humans-in-space/commercial-space/commercial-space-stations/"},{"title":"[MHRA: The Next Frontier—unlocking in-orbit manufacturing of medicines]","source":"","date":"","url":"https://medregs.blog.gov.uk/2026/06/25/the-next-frontier-unlocking-in-orbit-manufacturing-of-medicines/"},{"title":"[UK Space Agency Annual Report 2025–2026]","source":"","date":"","url":"https://www.gov.uk/government/publications/uk-space-agency-annual-report-and-accounts-2025-2026/uk-space-agency-annual-report-2025-2026"}],"images":[{"alt":"Candidate molecules travel to orbit and crystal samples return to Earth for analysis","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals-en/figure-01-en.webp"},{"alt":"Crystal growth under gravity compared with the potential effects of microgravity","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals-en/figure-02-en.webp"},{"alt":"Minimum viable value chain for space-enabled pharmaceutical research and manufacturing","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals-en/figure-03-en.webp"},{"alt":"Taiwan capability map from mission integration and launch-return logistics to planned X-ray crystallography","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals-en/figure-04-en.webp"}],"cover_image":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals-en/cover-en.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-07-24）。SpaceX Goes to Orbit. Is the Money in the Crystals?。https://drugnews.com.tw/articles/2026-07-24-spacex-microgravity-drug-crystals-en.html","disclaimer":"This article is intended for industry research and knowledge sharing only. It does not constitute investment, medical, fundraising, or individual stock advice.","translations":{"zh-Hant":"2026-07-24-spacex-microgravity-drug-crystals.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}